✨
AI Summary
- Dr. Nally discusses decision regret and toxicity perception in RCC patients.
- Findings from the 2026 ASCO Annual Meeting were examined.
- Focus on adjuvant pembrolizumab therapy and patient experience.
Guests on This Episode
EM
Elizabeth Nally, MBBS
1 podcast appearance